{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:24:24Z","timestamp":1794450264446,"version":"4.9.1"},"reference-count":84,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1136\/jnnp-2017-316201","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T21:00:17Z","timestamp":1502312417000},"page":"876-882","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":411,"title":["Peripheral inflammatory markers in Alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies"],"prefix":"10.1136","volume":"88","author":[{"given":"Ka Sing P","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina S","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano A","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Pakosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"key-10.1136\/jnnp-2017-316201-1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/gerona\/gls187","article-title":"The role of peripheral inflammatory markers in dementia and alzheimer\u2019s disease: a meta-analysis","volume":"68","author":"Koyama","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key-10.1136\/jnnp-2017-316201-2","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jalz.2014.02.001","article-title":"2014 alzheimer\u2019s disease facts and figures","volume":"10","author":"Alzheimer\u2019s Association","year":"2014","journal-title":"Alzheimers Dement"},{"key":"key-10.1136\/jnnp-2017-316201-3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"key-10.1136\/jnnp-2017-316201-4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer\u2019s disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol Rep"},{"key":"key-10.1136\/jnnp-2017-316201-5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2014.04.010","article-title":"Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits","volume":"185","author":"Agyare","year":"2014","journal-title":"J Control Release"},{"key":"key-10.1136\/jnnp-2017-316201-6","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"33","author":"Lee","year":"2010","journal-title":"Arch Pharm Res"},{"key":"key-10.1136\/jnnp-2017-316201-7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00702-006-0575-6","article-title":"The significance of neuroinflammation in understanding Alzheimer\u2019s disease","volume":"113","author":"Eikelenboom","year":"2006","journal-title":"J Neural Transm"},{"key":"key-10.1136\/jnnp-2017-316201-8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2008.05315.x","article-title":"Interleukin-1beta: a bridge between inflammation and excitotoxicity?","volume":"106","author":"Fogal","year":"2008","journal-title":"J Neurochem"},{"key":"key-10.1136\/jnnp-2017-316201-9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0002-9440(10)64787-6","article-title":"Astrocytic alterations in interleukin-6\/Soluble interleukin-6 receptor alpha double-transgenic mice","volume":"157","author":"Brunello","year":"2000","journal-title":"Am J Pathol"},{"key":"key-10.1136\/jnnp-2017-316201-10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"1-2","key":"key-10.1136\/jnnp-2017-316201-11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imbio.2004.04.001","article-title":"Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions","volume":"209","author":"Ancuta","year":"2004","journal-title":"Immunobiology"},{"issue":"1-2","key":"key-10.1136\/jnnp-2017-316201-12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(02)00207-1","article-title":"The role of macrophage\/microglia and astrocytes in the pathogenesis of three neurologic disorders: hiv-associated dementia, alzheimer disease, and multiple sclerosis","volume":"202","author":"Minagar","year":"2002","journal-title":"J Neurol Sci"},{"key":"key-10.1136\/jnnp-2017-316201-13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1189\/jlb.0206125","article-title":"CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells","volume":"80","author":"Ancuta","year":"2006","journal-title":"J Leukoc Biol"},{"key":"key-10.1136\/jnnp-2017-316201-14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.brainres.2010.10.053","article-title":"Anti-TNF-\u03b1 reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP\/PS1 transgenic mouse brains","volume":"1368","author":"Shi","year":"2011","journal-title":"Brain Res"},{"key":"key-10.1136\/jnnp-2017-316201-15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-11-30","article-title":"A pilot study on the use of interferon beta-1a in early alzheimer\u2019s disease subjects","volume":"11","author":"Grimaldi","year":"2014","journal-title":"J Neuroinflammation"},{"key":"key-10.1136\/jnnp-2017-316201-16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(01)00290-1","article-title":"Chemokines and Alzheimer\u2019s disease","volume":"22","author":"Streit","year":"2001","journal-title":"Neurobiol Aging"},{"key":"key-10.1136\/jnnp-2017-316201-17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-140006","article-title":"Altered serum levels of adipokines and insulin in probable alzheimer\u2019s disease","volume":"41","author":"Khemka","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2017-316201-18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12017-012-8201-2","article-title":"Decreased levels of circulating adiponectin in mild cognitive impairment and alzheimer\u2019s disease","volume":"15","author":"Teixeira","year":"2013","journal-title":"Neuromolecular Med"},{"key":"key-10.1136\/jnnp-2017-316201-19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11011-014-9501-z","article-title":"Obesity as a risk factor for alzheimer\u2019s disease: the role of adipocytokines","volume":"29","author":"Letra","year":"2014","journal-title":"Metab Brain Dis"},{"key":"key-10.1136\/jnnp-2017-316201-20","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","article-title":"Role of metabolism in neurodegenerative disorders","volume":"65","author":"Procaccini","year":"2016","journal-title":"Metabolism"},{"key":"key-10.1136\/jnnp-2017-316201-21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat Med"},{"key":"key-10.1136\/jnnp-2017-316201-22","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/1381612053381684","article-title":"Blood-brain barrier transport of cytokines: a mechanism for neuropathology","volume":"11","author":"Banks","year":"2005","journal-title":"Curr Pharm Des"},{"key":"key-10.1136\/jnnp-2017-316201-23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000096887","article-title":"Permeability of the blood-brain barrier to soluble cytokine receptors","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"key-10.1136\/jnnp-2017-316201-24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.euroneuro.2014.03.002","article-title":"Obesity and dementia: adipokines interact with the brain","volume":"24","author":"Arnoldussen","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.1136\/jnnp-2017-316201-25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"A meta-analysis of cytokines in alzheimer\u2019s disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol Psychiatry"},{"key":"key-10.1136\/jnnp-2017-316201-26","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1-2","key":"key-10.1136\/jnnp-2017-316201-27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virol.2013.09.014","article-title":"Mitigation of variation observed in a peripheral blood mononuclear cell (PBMC) based HIV-1 neutralization assay by donor cell pooling","volume":"447","author":"Wieczorek","year":"2013","journal-title":"Virology"},{"key":"key-10.1136\/jnnp-2017-316201-28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2164-11-96","article-title":"Variability of gene expression profiles in human blood and lymphoblastoid cell lines","volume":"11","author":"Min","year":"2010","journal-title":"BMC Genomics"},{"key":"key-10.1136\/jnnp-2017-316201-29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1101\/lm.024018.111","article-title":"Working memory, long-term memory, and medial temporal lobe function","volume":"19","author":"Jeneson","year":"2012","journal-title":"Learn Mem"},{"key":"key-10.1136\/jnnp-2017-316201-30","unstructured":"GA Wells BS , O\u2019Connell D , Peterson J , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"key":"key-10.1136\/jnnp-2017-316201-31","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key-10.1136\/jnnp-2017-316201-32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1536867X0800800102","article-title":"Metan: fixed- and random-effects meta-analysis","volume":"8","author":"Harris RJ","year":"2008","journal-title":"Stata J"},{"key":"key-10.1136\/jnnp-2017-316201-33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1515\/CCLM.2008.182","article-title":"An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA","volume":"46","author":"Noble","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"key-10.1136\/jnnp-2017-316201-34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key-10.1136\/jnnp-2017-316201-35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The Mini-Mental state examination","volume":"40","author":"Folstein","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.1136\/jnnp-2017-316201-36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"key-10.1136\/jnnp-2017-316201-37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fneur.2015.00181","article-title":"Central Nervous System and peripheral inflammatory processes in alzheimer\u2019s Disease: Biomarker Profiling Approach","volume":"6","author":"Delaby","year":"2015","journal-title":"Front Neurol"},{"key":"key-10.1136\/jnnp-2017-316201-38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0361-9230(03)00088-1","article-title":"Cerebral pattern of pro- and anti-inflammatory cytokines in dementias","volume":"61","author":"Tarkowski","year":"2003","journal-title":"Brain Res Bull"},{"key":"key-10.1136\/jnnp-2017-316201-39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.biopsych.2008.07.019","article-title":"All-or-nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer\u2019s beta-amyloid peptide","volume":"64","author":"Teixeira","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key-10.1136\/jnnp-2017-316201-40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1874205X01509010009","article-title":"Homocysteine induced cerebrovascular dysfunction: a link to alzheimer\u2019s Disease Etiology","volume":"9","author":"Kamat","year":"2015","journal-title":"Open Neurol J"},{"key":"key-10.1136\/jnnp-2017-316201-41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JAD-2009-1126","article-title":"Systemic inflammation and the risk of alzheimer\u2019s disease and dementia: a prospective population-based study","volume":"18","author":"Sundel\u00f6f","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2017-316201-42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.04.001","article-title":"The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review","volume":"55","author":"Bao","year":"2014","journal-title":"J Autoimmun"},{"issue":"3-4","key":"key-10.1136\/jnnp-2017-316201-43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01877210","article-title":"Cytokines and the immune response","volume":"8","author":"Van der Meide","year":"1996","journal-title":"Biotherapy"},{"key":"key-10.1136\/jnnp-2017-316201-44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000071472","article-title":"Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes","volume":"10","author":"Banks","year":"2002","journal-title":"Neuroimmunomodulation"},{"key":"key-10.1136\/jnnp-2017-316201-45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbi.2004.01.004","article-title":"The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease","volume":"18","author":"Perry","year":"2004","journal-title":"Brain Behav Immun"},{"key":"key-10.1136\/jnnp-2017-316201-46","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s11064-012-0750-0","article-title":"Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in alzheimer\u2019s disease and vascular dementia","volume":"37","author":"Uslu","year":"2012","journal-title":"Neurochem Res"},{"key":"key-10.1136\/jnnp-2017-316201-47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064971","article-title":"Inflammatory proteins in plasma are associated with severity of alzheimer\u2019s disease","volume":"8","author":"Leung","year":"2013","journal-title":"PLoS One"},{"key":"key-10.1136\/jnnp-2017-316201-48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0404.1997.tb00275.x","article-title":"Serum interleukin-6 levels correlate with the severity of dementia in down syndrome and in alzheimer\u2019s disease","volume":"96","author":"K\u00e1lm\u00e1n","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"key-10.1136\/jnnp-2017-316201-49","first-page":"55","article-title":"Study of interleukin-6 production in alzheimer\u2019s disease","volume":"49","author":"Cojocaru","year":"2011","journal-title":"Rom J Intern Med"},{"issue":"25-26","key":"key-10.1136\/jnnp-2017-316201-50","first-page":"787","article-title":"[Systemic changes of the immune system in patients with Alzheimer\u2019s dementia]","volume":"123","author":"Leblhuber","year":"1998","journal-title":"Dtsch Med Wochenschr"},{"key":"key-10.1136\/jnnp-2017-316201-51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000071001","article-title":"Inflammatory markers in matched plasma and cerebrospinal fluid from patients with alzheimer\u2019s disease","volume":"16","author":"Sun","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"key-10.1136\/jnnp-2017-316201-52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.exger.2004.01.009","article-title":"Inflammatory mediators in the elderly","volume":"39","author":"Krabbe","year":"2004","journal-title":"Exp Gerontol"},{"key":"key-10.1136\/jnnp-2017-316201-53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ"},{"key":"key-10.1136\/jnnp-2017-316201-54","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.10.012","article-title":"Soluble TNF receptors are associated with A\u03b2 metabolism and conversion to dementia in subjects with mild cognitive impairment","volume":"31","author":"Buchhave","year":"2010","journal-title":"Neurobiol Aging"},{"key":"key-10.1136\/jnnp-2017-316201-55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JAD-121558","article-title":"Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of alzheimer\u2019s disease patients","volume":"34","author":"Laske","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2017-316201-56","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3233\/JAD-2010-100921","article-title":"Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"22","author":"Diniz","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"1-2","key":"key-10.1136\/jnnp-2017-316201-57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2008.12.007","article-title":"Chronic CXCL10 alters neuronal properties in rat hippocampal culture","volume":"207","author":"Cho","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"key-10.1136\/jnnp-2017-316201-58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2004.07.009","article-title":"The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons","volume":"156","author":"Nelson","year":"2004","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2017-316201-59","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1460-9568.2006.04631.x","article-title":"CXCL10-induced cell death in neurons: role of calcium dysregulation","volume":"23","author":"Sui","year":"2006","journal-title":"Eur J Neurosci"},{"key":"key-10.1136\/jnnp-2017-316201-60","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/pr300895r","article-title":"Secretome analyses of A\u03b2(1-42) stimulated hippocampal astrocytes reveal that CXCL10 is involved in astrocyte migration","volume":"12","author":"Lai","year":"2013","journal-title":"J Proteome Res"},{"key":"key-10.1136\/jnnp-2017-316201-61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1590\/S0004-282X2011000400009","article-title":"Chemokines in CSF of alzheimer\u2019s disease patients","volume":"69","author":"Corr\u00eaa","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"key":"key-10.1136\/jnnp-2017-316201-62","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1016\/S0021-9258(18)61039-7","article-title":"Mechanism of action of monoclonal antibodies that block the light activation of the guanyl nucleotide-binding protein, transducin","volume":"262","author":"Hamm","year":"1987","journal-title":"J Biol Chem"},{"key":"key-10.1136\/jnnp-2017-316201-63","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH14-11-0938","article-title":"Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in alzheimer\u2019s dementia","volume":"114","author":"Huang","year":"2015","journal-title":"Thromb Haemost"},{"key":"key-10.1136\/jnnp-2017-316201-64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nbd.2014.04.012","article-title":"Neuroprotective effects of leptin in the context of obesity and metabolic disorders","volume":"72 Pt A","author":"Davis","year":"2014","journal-title":"Neurobiol Dis"},{"key":"key-10.1136\/jnnp-2017-316201-65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1567205010666131212114156","article-title":"Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential","volume":"11","author":"Johnston","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"key-10.1136\/jnnp-2017-316201-66","first-page":"11","article-title":"Epidermal growth factor: the receptor and its function","volume":"2","author":"Todderud","year":"1989","journal-title":"Biofactors"},{"key":"key-10.1136\/jnnp-2017-316201-67","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2174\/1389557516666160321114917","article-title":"Review on EGFR inhibitors: critical updates","volume":"16","author":"Singh","year":"2016","journal-title":"Mini Rev Med Chem"},{"key":"key-10.1136\/jnnp-2017-316201-68","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1016\/S0021-9258(19)38983-5","article-title":"Epidermal growth factor","volume":"265","author":"Carpenter","year":"1990","journal-title":"J Biol Chem"},{"key":"key-10.1136\/jnnp-2017-316201-69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/acn3.299","article-title":"Plasma EGF and cognitive decline in Parkinson\u2019s disease and Alzheimer\u2019s disease","volume":"3","author":"Lim","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"key-10.1136\/jnnp-2017-316201-70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0301-0082(96)00009-3","article-title":"Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain","volume":"49","author":"Ferrer","year":"1996","journal-title":"Prog Neurobiol"},{"key":"key-10.1136\/jnnp-2017-316201-71","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-199306000-00054","article-title":"Induction of beta-amyloid precursor protein isoform mRNAs by bFGF in astrocytes","volume":"4","author":"Gray","year":"1993","journal-title":"Neuroreport"},{"key":"key-10.1136\/jnnp-2017-316201-72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exger.2009.09.005","article-title":"Blood-based biomarkers of microvascular pathology in alzheimer\u2019s disease","volume":"45","author":"Ewers","year":"2010","journal-title":"Exp Gerontol"},{"key":"key-10.1136\/jnnp-2017-316201-73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9343(99)00153-9","article-title":"Cellular adhesion molecules and atherogenesis","volume":"107","author":"Price","year":"1999","journal-title":"Am J Med"},{"key":"key-10.1136\/jnnp-2017-316201-74","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/ars.2010.3522","article-title":"Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants","volume":"15","author":"Cook-Mills","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"key-10.1136\/jnnp-2017-316201-75","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-122359","article-title":"Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in alzheimer\u2019s disease","volume":"35","author":"Hall","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"key-10.1136\/jnnp-2017-316201-76","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1080\/00207450701392068","article-title":"Cytokines in alzheimer\u2019s disease and vascular dementia","volume":"118","author":"Angelopoulos","year":"2008","journal-title":"Int J Neurosci"},{"key":"key-10.1136\/jnnp-2017-316201-77","first-page":"75","article-title":"Plasma beta amyloid and cytokine profile in women with alzheimer\u2019s disease","volume":"29","author":"Baranowska-Bik","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"issue":"1-2","key":"key-10.1136\/jnnp-2017-316201-78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2007.10.020","article-title":"Systemic immune aberrations in alzheimer\u2019s disease patients","volume":"193","author":"Bonotis","year":"2008","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2017-316201-79","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","article-title":"Treatment for Rheumatoid Arthritis and Risk of Alzheimer\u2019s Disease: A Nested Case-Control Analysis","volume":"30","author":"Chou","year":"2016","journal-title":"CNS Drugs"},{"key":"key-10.1136\/jnnp-2017-316201-80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14737175.2016.1200972","article-title":"Targeting neuroinflammation in Alzheimer\u2019s disease: evidence for NSAIDs and novel therapeutics","volume":"17","author":"Deardorff","year":"2017","journal-title":"Expert Rev Neurother"},{"key":"key-10.1136\/jnnp-2017-316201-81","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2826.2011.02161.x","article-title":"Mechanisms of glucocorticoids in the control of neuroinflammation","volume":"24","author":"Schweingruber","year":"2012","journal-title":"J Neuroendocrinol"},{"key":"key-10.1136\/jnnp-2017-316201-82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S75546","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"11","author":"Zhang","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key-10.1136\/jnnp-2017-316201-83","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2016.06.014","article-title":"Insights on the pathophysiology of alzheimer\u2019s disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system","volume":"68","author":"D\u00e1 Mesquita","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"key-10.1136\/jnnp-2017-316201-84","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1742-4658.2007.05673.x","article-title":"Metabonomics in pharmaceutical r&d","volume":"274","author":"Lindon","year":"2007","journal-title":"Febs J"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2017-316201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T19:53:18Z","timestamp":1659297198000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2017-316201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":84,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,9,11]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/jnnp-2017-316201"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2017-316201","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}